医生介绍
· Female
· Multidisciplinary Team(s)
· Head & Neck Oncology
Melanoma/Skin
Thoracic Oncology
· Department/Research Program(s)
· Dept of Oncology
· Cancer Type(s)
· Hypopharynx (pyriform Sinus)
Laryngeal Cancer
Lip/Oral Cavity (hard palate
Lung Cancer (Small Cell & Non-Small Cell)
Melanoma
Merkel Cell Carcinoma
Neck Cancer
Nose Cancer
Oral Cavity Cancer (Mouth)
Oropharynx (soft palate
Sinus Cancer
Skin Cancer (Basal & Squamous Cell)
Throat Cancer
Thymus Gland Cancer
Thyroid Cancer
· Contact Info
· Email:
weisea@karmanos.org
· Education
· Fellowship
Hematology/Oncology, Karmanos Cancer Institute
Medical School
Michigan State University, College of Osteopathic Medicine
Residency
Internal Medicine, Eastern Virginia Medical School
· Professional Memberships/Associations
· AOA
AMA
ASCO
· Board Certifications
· American Board Certified, Internal Medicine
American Board Certified, Medical Oncology
· Clinical Interests
· Medical oncology Clinical Research
· Research Interests
· Scientific research aimed at harnessing the bodies own immune system to combat the initiation and spread of cancer. Multidisciplinary care of patients with breast cancer.
· Profile
· I am a native of Michigan, attended Alma College for undergraduate education, then Michigan State University for medical school. Following medical school, I served in the Navy for 5 years as a general medical officer. After military service, I completed my Internal Medicine Residency at EVMS in Norfolk, then returned to Michigan for Hematology/oncology Fellowship. I have spent 3 years in a research lab with Dr. Wei, investigating a DNA vacciine for Her2 positive breast cancer. I have worked in several fields of Oncology, including Phase I clinical trials with Dr. LoRusso. Currently, I am working with the Thoracic team, the Head & Neck team, and the Melanoma team to provide state of the art oncology care and clinical trial research.
· Publications
· Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity. Cancer Immunology and Immunotherapy. Assisted with laboratory experiments. Contributed to content and editing of final paper. October 3, 2008. [Epub ahead of print]. Authors: Whittington, P.J., Radkovich-Brown, O., Jacob, J.B., Jones, R.F., Weise, A.M., Wei, W.Z.
expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Res Treat. 2009 Mar 24. Authors: Fu, J., Weise, A.M., Falany, J.L., Falany, C.N., Thibodeau, B.J., Miller, F.R., Kocarek, T.A., Runge-Morris, M.
Fatal Liver Failure in a Patient on Acetaminophen Treated with the Tyrosine Kinase Inhibitor Sunitinib Malate. The Annals of Pharmacotherapy April 2009. Authors: Weise, A.M., Chin, L., Shields, A.F.
Combining Human and Rat Sequences in Her-2 DNA Vaccines Blunts Immune Tolerance and Drives Antitumor Immunity. Cancer Res. 2010. Authors: Jacob, J.B., Quaglino, E., Radkevich-Brown, O., Jones, R.F., Piechocki, M.P., Reyes, J.D., Weise, A.M., Amici, A., Wei, W.
Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression, Cancer Immunol Immunother, 2010 Mar;59(3):409-17. PMID: 19730859 Authors: Radkevich-Brown O, Piechocki MP, Back JB, Weise AM, Pilon-Thomas S, Wei WZ.
相关报道资讯
首页
咨询
方舟新药
营养商城